HealthEquity (NASDAQ:HQY) EVP Sunil Rajasekar Sells 108 Shares of Stock

Key Points

• HealthEquity EVP Sunil Rajasekar sold 108 shares at an average price of $105.60, totaling $11,404.80. The sale reduced his holdings by 0.20%, leaving him with 53,297 shares valued at approximately $5.63 million.
• HealthEquity recently reported quarterly EPS of $1.24, beating estimates of $1.19, while revenue rose 95.5% year over year to $350.73 million. The company set fiscal 2027 EPS guidance at $4.66–$4.73.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $112.20, compared with a recent share price of $93.07.

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) EVP Sunil Rajasekar sold 108 shares of HealthEquity stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $105.60, for a total transaction of $11,404.80. Following the sale, the executive vice president directly owned 53,297 shares of the company's stock, valued at $5,628,163.20. The trade was a 0.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Sunil Rajasekar also recently made the following trade(s):

• On Thursday, October 15th, Sunil Rajasekar purchased 108 shares of HealthEquity stock. The stock was bought at an average cost of $90.33 per share, for a total transaction of $9,755.64.

HealthEquity Stock Performance

HealthEquity stock traded up $1.04 during trading hours on Monday, hitting $93.07. The company had a trading volume of 532,932 shares, compared to its average volume of 944,347. The firm has a 50-day moving average of $96.08 and a 200 day moving average of $91.47. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. The firm has a market cap of $7.70 billion, a PE ratio of 33.60, a PEG ratio of 1.45 and a beta of 0.24. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $107.62.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The company had revenue of $350.73 million during the quarter, compared to analysts' expectations of $349.22 million. The company's quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, sell-side analysts expect that HealthEquity, Inc. will post 3.93 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Leonteq Securities AG raised its position in shares of HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company's stock valued at $32,000 after buying an additional 235 shares in the last quarter. Silvant Capital Management LLC acquired a new stake in HealthEquity during the second quarter worth approximately $35,000. Axiom Investment Management LLC acquired a new stake in HealthEquity during the first quarter worth approximately $33,000. Public Employees Retirement System of Ohio acquired a new stake in HealthEquity during the second quarter worth approximately $39,000. Finally, Caitong International Asset Management Co. Ltd increased its stake in HealthEquity by 2,476.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 438 shares of the company's stock worth $40,000 after acquiring an additional 421 shares during the period. 99.55% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on HQY shares. Raymond James Financial restated a "strong-buy" rating on shares of HealthEquity in a research note on Thursday, September 3rd. Deutsche Bank Aktiengesellschaft increased their price objective on HealthEquity from $135.00 to $142.00 and gave the stock a "buy" rating in a research report on Monday, August 31st. Telsey Advisory Group set a $111.00 target price on HealthEquity in a report on Friday, August 28th. Citigroup reissued a "market outperform" rating on shares of HealthEquity in a research report on Friday, August 28th. Finally, BTIG Research restated a "buy" rating and issued a $115.00 price target on shares of HealthEquity in a research note on Friday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $112.20.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company's offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.